Systematic review of the frequency and outcomes of non-cardiac surgery after drug-eluting stent implantation

Hellenic Journal of Cardiology

Volumn 52, Issue 2, 2011, Pages 141-148

  Alshawabkeh, Laith I ^a   Banerjee, Subhash ^b   Brilakis, Emmanouil S ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Drug eluting stents; Non cardiac surgery; References; Stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PRASUGREL; THIENOPYRIDINE DERIVATIVE; TIROFIBAN;

ADVERSE OUTCOME; ANTICOAGULANT THERAPY; BARE METAL STENT; BLEEDING; BLOOD TRANSFUSION; CORONARY ARTERY BYPASS GRAFT; DRUG ELUTING STENT; HUMAN; LOADING DRUG DOSE; NONCARDIAC SURGERY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIOPERATIVE COMPLICATION; REVIEW; SAPHENOUS VEIN GRAFT; STENT THROMBOSIS; SURGERY; SURGICAL RISK; SYSTEMATIC REVIEW;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY DISEASE; DRUG-ELUTING STENTS; HUMANS; SURGICAL PROCEDURES, OPERATIVE; TREATMENT OUTCOME;

EID: 79955136499     PISSN: 10117970     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Kaluza GL, Joseph J, Lee JR, Raizner ME, Raizner AE. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol. 2000; 35: 1288-1294.
2. Wilson SH, Fasseas P, Orford JL, et al. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol. 2003; 42: 234-240.
3. Sharma AK, Ajani AE, Hamwi SM, et al. Major noncardiac surgery following coronary stenting: when is it safe to operate? Catheter Cardiovasc Interv. 2004; 63: 141-145.
4. Reddy PR, Vaitkus PT. Risks of noncardiac surgery after coronary stenting. Am J Cardiol. 2005; 95: 755-757.
5. Brilakis ES, Banerjee S, Berger PB. Perioperative management of patients with coronary stents. J Am Coll Cardiol. 2007; 49: 2145-2150.
6. Berger PB, Kleiman NS, Pencina MJ, et al. Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. JACC Cardiovasc Interv. 2010; 3: 920-927.
7. Cruden NLM, Harding SA, Flapan AD, et al. Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery. Circ Cardiovasc Interv. 2010; 3: 236-242.
8. van Kuijk J-P, Flu W-J, Schouten O, et al. Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents. Am J Cardiol. 2009; 104: 1229-1234.
9. Assali A, Vaknin-Assa H, Lev E, et al. The risk of cardiac complications following noncardiac surgery in patients with drug eluting stents implanted at least six months before surgery. Catheter Cardiovasc Interv. 2009; 74: 837-843.
10. Anwaruddin S, Askari AT, Saudye H, et al. Characterization of post-operative risk associated with prior drug-eluting stent use. JACC Cardiovasc Interv. 2009; 2: 542-549.
11. Kim H-L, Park K-W, Kwak J-J, et al. Stent-related cardiac events after non-cardiac surgery: drug-eluting stent vs. bare metal stent. Int J Cardiol. 2008; 123: 353-354.
12. Godet G, Le Manach Y, Lesache F, Perbet S, Coriat P. Drug-eluting stent thrombosis in patients undergoing non-cardiac surgery: is it always a problem? Br J Anaesth. 2008; 100: 472-477.
13. Rabbitts JA, Nuttall GA, Brown MJ, et al. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology. 2008; 109: 596-604.
14. Rhee SJ, Yun KH, Lee SR, et al. Drug-eluting stent thrombosis during perioperative period. Int Heart J. 2008; 49: 135-142.
15. Choi C, Rha S, Jin Z, et al. The optimal timing for non-cardiac surgery after percutaneous coronary intervention with drug-eluting stents. Int J Cardiol. 2010; 139: 313-316.
16. Schouten O, van Domburg RT, Bax JJ, et al. Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol. 2007; 49: 122-124.
17. Brotman DJ, Bakhru M, Saber W, et al. Discontinuation of antiplatelet therapy prior to low-risk noncardiac surgery in patients with drug-eluting stents: a retrospective cohort study. J Hosp Med. 2007; 2: 378-384.
18. Compton PA, Zankar AA, Adesanya AO, Banerjee S, Brilakis ES. Risk of noncardiac surgery after coronary drug-eluting stent implantation. Am J Cardiol. 2006; 98: 1212-1213.
19. Gandhi NK, Abdel-Karim Md AR, Banerjee S, Brilakis ES. Frequency and risk of noncardiac surgery after drug-eluting stent implantation. Catheter Cardiovasc Interv. 2010 Sep 7. [Epub ahead of print]
20. Foo F, Sanfilippo F, Norman P, et al. Cardiac risks of performing non-cardiac procedures within a year of coronary revascularisation. Heart Lung Circ. 2009; 18: S202.
21. To A, Armstrong G, Zeng I, Webster M. Noncardiac surgery and bleeding after percutaneous coronary intervention. Circ Cardiovasc Interv. 2009; 2: 213-221.
22. Schouten O, Domburg RTV, Bax JJ, et al. Cardiac outcome after noncardiac surgery in patients with recent coronary stenting. Eur Heart J. 2006; 27 Supplement 1: 86.
23. Vicenzi MN, Meislitzer T, Heitzinger B, Halaj M, Fleisher LA, Metzler H. Coronary artery stenting and non-cardiac surgery--a prospective outcome study. Br J Anaesth. 2006; 96: 686-693.
24. Layland J, Jellis C, Whitbourn R. Extremely late drug-eluting stent thrombosis: 2037 days after deployment. Cardiovasc Revasc Med. 2009; 10: 55-57.
25. Brilakis ES, Orford JL, Fasseas P, et al. Outcome of patients undergoing balloon angioplasty in the two months prior to noncardiac surgery. Am J Cardiol. 2005; 96: 512-514.
26. Piscione F, Cassese S, Galasso G, et al. A new approach to percutaneous coronary revascularization in patients requiring undeferrable non-cardiac surgery. International journal of cardiology. Int J Cardiol. 2011; 146: 399-403.
27. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005; 293: 2126-2130.
28. Tompkins C, Cheng A, Dalal D, et al. Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation. J Am Coll Cardiol. 2010; 55:2376-2382.
29. Grines CL, Bonow RO, Casey DE, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol. 2007; 49: 734-739.
30. Khair T, Garcia BA, Banerjee S, Brilakis ES. Contemporary approaches to perioperative management of coronary stents and to preoperative coronary revascularization: a survey of 374 interventional cardiologists. Cardiovasc Revasc. Med. 2010: in press.
31. Eisenberg MJ, Richard PR, Libersan D, Filion KB. Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents. Circulation. 2009; 119: 1634-1642.
32. Burger W, Chemnitius J-M, Kneissl GD, Rücker G. Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Intern Med. 2005; 257: 399-414.
33. Oscarsson A, Gupta A, Fredrikson M, et al. To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth. 2010; 104: 305-312.
34. Enver MK, Hoh I, Chinegwundoh FI. The management of aspirin in transurethral prostatectomy: current practice in the UK. Ann R Coll Surg Engl. 2006; 88: 280-283.
35. Brilakis ES, Banerjee S, Berger PB. Perioperative management of patients with coronary stents. J Am Coll Cardiol. 2007; 49: 2145-2150.
36. Savonitto S, D'Urbano M, Caracciolo M, et al. Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of 'bridging' antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. Br J Anaesth. 2010; 104: 285-291.
37. Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007; 357: 2001-2015.
38. Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009; 361: 1045-1057.